Federal drug regulators failed to grant Merck approval to expand the use of its cervical-cancer vaccine Gardasil to older women, the company said in a statement posted on its website.
Merck, which is based in Whitehouse Station, had sought approval from the Food and Drug Administration to market the vaccine to women between the ages of 27 and 45.
via nj.com
No comments:
Post a Comment